Liver cirrhosis and hepatocellular carcinoma in Mexico: impact of chronic infection by hepatitis viruses B and C
Open accessThe claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Heavy alcohol consumption is likely to be the main cause of liver cirrhosis in most parts of Latin America.
“Heavy alcohol consumption is likely to be the main cause of liver cirrhosis in most parts of Latin America [20,70–72] (Figure 2, Additional file 6: Table S6).”
From Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis (2014) · cites this paper as [71]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Molecular viral oncology of hepatocellular carcinoma
Block, T. M., Mehta, A. S., Fimmel, C. J., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206557 · Cited by 500 · see citing works
Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis
Velázquez, R. F., Rodríguez, M., Navascués, C., Linares, A., Pérez, R., Sotorríos, N. G., Martínez, I., & Rodrigo, L. (2003) · Hepatology · doi:10.1053/jhep.2003.50093 · Cited by 457 · see citing works
El‐Serag, H. B., Mason, A. C., & Key, C. R. (2001) · Hepatology · doi:10.1053/jhep.2001.21041 · Cited by 356 · see citing works
Riesgos, C., Seguro, M. D., Estado, S. D. L. T. D., & Química, F. D. (2006) · Cited by 315 · see citing works
Management of chronic hepatitis B
Conjeevaram, H. S., & Lok, A. S.-F. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00431-2 · Cited by 257 · see citing works
Stevens, G., Dias, R. H., Thomas, K. J. A., Rivera, J. A., Carvalho, N., Barquera, S., Hill, K., & Ezzati, M. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050125 · Cited by 249 · see citing works
Worldwide mortality from cirrhosis: An update to 2002
Bosetti, C., Levi, F., Lucchini, F., Zatonski, W. A., Negri, E., & La Vecchia, C. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.01.025 · Cited by 230 · see citing works
Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data
Méndez‐Sánchez, N., Villa, A. R., Chávez-Tapia, N. C., et al. (2005) · Annals of Hepatology · doi:10.1016/s1665-2681(19)32086-1 · Cited by 127 · see citing works
Hepatitis B epidemiology in Latin America
Tanaka, J. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00455-7 · Cited by 116 · see citing works
Etiology of Liver Cirrhosis in Mexico
Méndez-Sánchez, N., Aguilar-Ramírez, J. R., Reyes, A., Dehesa, M., Juárez, A., Castañeda, B., Sánchez-Avila, F., Poo, J. L., Guevara González, L., Lizardi, J., et al. (2004) · Annals of Hepatology · doi:10.1016/s1665-2681(19)32122-2 · Cited by 106 · see citing works
Chronic Viral Hepatitis and Hepatocellular Carcinoma
Barazani, Y., Hiatt, J. R., Tong, M. J., et al. (2007) · World Journal of Surgery · doi:10.1007/s00268-007-9041-3 · Cited by 98 · see citing works
The prevention of infection-associated cancers
Flora, S. D., & Bonanni, P. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr054 · Cited by 98 · see citing works
[Epidemiology of viral hepatitis in Mexico].
Panduro, A., Meléndez, G. E., Fierro, N. A., et al. (2011) · PubMed · Cited by 75 · see citing works
Steatosis and insulin resistance in hepatitis C: A way out for the virus?
Campo, J. A. D., & Romero‐Gómez, M. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.5014 · Cited by 73 · see citing works
Occult hepatitis B in the genotype H‐infected Nahuas and Huichol native Mexican population
Román, S., Tanaka, Y., Khan, A., et al. (2010) · Journal of Medical Virology · doi:10.1002/jmv.21846 · Cited by 65 · see citing works
Seroprevalencia de la hepatitis C en adultos de México: ¿un problema de salud pública emergente?
Valdespino, J. L., Conde-González, C. J., Olaiz-Fernández, G., Palma, O., Kershenobich, D., & Sepúlveda, J. (2007) · Salud Pública de México · doi:10.1590/s0036-36342007000900011 · Cited by 57 · see citing works
Low Prevalence of Anti-Hepatitis C Virus Antibodies in Mexico: A Systematic Review
Chiquete, E., & Panduro, A. (2006) · Intervirology · doi:10.1159/000096306 · Cited by 46 · see citing works
Burguete-García, A. I., Conde-González, C. J., Jiménez‐Méndez, R., et al. (2011) · PubMed · Cited by 45 · see citing works
Self-citationMortality trends for liver cancer in Mexico from 2000 to 2006
Méndez‐Sánchez, N., Villa, A. R., Vázquez‐Elizondo, G., et al. (2008) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31852-6 · Cited by 45 · see citing works
Prevalence of hepatitis C virus in the Mexican population: A systematic review
Santos‐López, G., Sosa-Jurado, F., Vallejo‐Ruiz, V., et al. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.02.001 · Cited by 43 · see citing works
Méndez‐Sánchez, N., García-Villegas, E. A., Merino-Zeferino, B., et al. (2010) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31619-9 · Cited by 35 · see citing works
Prevalencia en México de la infección y el estado de portador de la hepatitis B en adultos
Valdespino, J. L., Conde-González, C. J., Olaiz-Fernández, G. A., et al. (2007) · Salud Pública de México · doi:10.1590/s0036-36342007000900012 · Cited by 31 · see citing works
Seroepidemiology of the hepatitis B and delta in the southeast of Chiapas, Mexico.
Alvarez-Muñoz, T., Bustamante-Calvillo, M. E., Martínez-García, C., et al. (1990) · PubMed · Cited by 21 · see citing works
[Liver cirrhosis mortality in Mexico. I. Relevant epidemiological characteristics].
Narro-Robles, J., GUTIÉRREZ-AVILA, J. H., López‐Cervantes, M., et al. (1992) · PubMed · Cited by 17 · see citing works
[Hepatocellular carcinoma. Experience at the Instituto Nacional de Cancerología].
Mondragón–Sánchez, R., Carrillo, F. J. O., Molina, J. D. D. L. M., et al. (1997) · PubMed · Cited by 16 · see citing works
In whom, how and how often is surveillance for hepatocellular carcinoma cost-effective?
Villavicencio, A. L. R., & Vargas-Vorácková, F. (2004) · Annals of Hepatology · doi:10.1016/s1665-2681(19)32093-9 · Cited by 10 · see citing works
Heterogeneous distribution of hepatitis B serological markers in rural areas of Mexico.
Juárez-Figueroa, L. A., Uribe-Salas, F. J., & Conde-González, C. J. (2011) · PubMed · Cited by 5 · see citing works
[Hepatitis C as a public health problem in Mexico].
(2011) · PubMed · Cited by 5 · see citing works
Flagged first, then by citations
Research works printed but not linked: 2
- Narro-Robles J, Gutiérrrez-Ávila H, López-Cervantes M, Borges G, Rosovosky H. La mortalidad por cirrhosis hepati- ca en México I. Características epidemiológicas relevan- tes. Sal Púb Méx 1992; 34(4): 378-87.
- González-Huezo MS, Sánchez-Hernández E, Camacho MC. Prevalencia de marcadores positivos para hepatitis B (Ags- VHB) y hepatitis C (Anti-VHC) en personal de salud del IS- SEMYM (Instituto de Seguridad Social del Estado de México y municipios). Rev Gastroenterol Mex 2010; 75(3): 4-11.
Cited by
Sorted by citations
Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis
Mokdad, A. A., Lopez, A. D., Shahraz, S., Lozano, R., Mokdad, A. H., Stanaway, J., Murray, C. J., & Naghavi, M. (2014) · BMC Medicine · doi:10.1186/s12916-014-0145-y · Cited by 1,129 · see citing works
- Authors
- Torres-Poveda, K., Burguete-García, A. I., & Madrid-Marina, V.
- Affiliations
- Instituto Nacional de Salud Pública (MX)
- Venue
- Annals of Hepatology
- Publisher
- Elsevier BV
- Published
- 2011-10
- Volume
- 10
- Issue
- 4
- Pages
- 556-558
- ISSN
- 1665-2681 (ISSN-L)
- OpenAlex
- W2401757052
- Cited by
- 18
- References
- 28
- Citations by year
- 2023: 1 · 2022: 2 · 2021: 3 · 2020: 2 · 2019: 1 · 2016: 1 · 2014: 6 · 2013: 2
- FWCI
- 1.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Annals of Hepatology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Keywords
- liver cirrhosis, hepatocellular carcinoma, hepatitis B virus, hepatitis C virus, chronic viral hepatitis, Mexico
- MeSH terms
- Humans, Liver Cirrhosis, Liver Neoplasms, Mexico, Risk Factors, Time Factors, Prevalence, Hepatitis B, Chronic, Hepatitis C, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
